<DOC>
	<DOC>NCT00401310</DOC>
	<brief_summary>The safety and efficacy of MK0724 will be assessed in patients with acute middle cerebral artery stroke using the Action Reach Arm Test (ARAT). This test allows measurement of a specific functional deficit and subsequent recovery correlating with the specific area of stroke in the brain.</brief_summary>
	<brief_title>The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018)</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Infarction, Middle Cerebral Artery</mesh_term>
	<mesh_term>Trauma, Nervous System</mesh_term>
	<criteria>1880 yrs of age inclusive Patient is able to receive IV infusion 836 hours after stroke onset Baseline NIHSS of 618 inclusive Patient had another stroke within 3 months preceding current stroke, patient's stroke is of origin other than MCA (e.g., nonischemic, hemorrhage), significant cerebral edema, abnormal liver enzymes and abnormal renal and hepatic functions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>